Clinical trial
ProLARS Trial: Prospective Longitudinal Follow-up of Low Anterior Resection Syndrome (LARS) and COREFO Score After Rectum Surgery in Patients Undergoing Upfront Surgery or Different Neo-adjuvant Treatment Regimens
NCT07339904 is registered in ClinicalTrials.gov with University Hospital, Antwerp as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- ProLARS Trial: Prospective Longitudinal Follow-up of Low Anterior Resection Syndrome (LARS) and COREFO Score After Rectum Surgery in Patients Undergoing Upfront Surgery or Different Neo-adjuvant Treatment Regimens
- Lead sponsor
- University Hospital, Antwerp
- Phase
- Not applicable
- Overall status
- Recruiting
- Start date
- August 26, 2024
- Completion date
- August 31, 2029
- Enrollment
- 100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
lars - low anterior resection syndrome, low anterior resection, rectal adenocarcinoma, rectal resection, total mesorectal excision